الباحثون

Hossein Keshavarz

المنشورات 13

مقال مراجعة وصول مفتوح

Current and Emerging Techniques for Diagnosis of Toxoplasmosis in Pregnancy: A Narrative Review

Aref Teimouri, Shima Mahmoudi, Atefeh Behkar وآخرون · Iranian Journal of Parasitology · 2024 · 10.18502/ijpa.v19i4.17159

Toxoplasma gondii is an intracellular parasite capable of crossing the placenta in pregnancy and infecting the developing fetus, leading to various congenital anomalies and even abortion. Acute Toxoplasma infection is responsible for almost all cases of congenital toxoplasmosis in immunocompetent pregnant women. Prenat …

مقال بحثي وصول مفتوح

The Therapeutic Efficacy of Zinc Oxide Nanoparticles on Acute Toxoplasmosis in BALB/c Mice

Kiana Rafei Siahkal, Hossein Keshavarz, Saeedeh Shojaee وآخرون · Iranian Journal of Parasitology · 2023 · 10.18502/ijpa.v18i4.14259

Background: Toxoplasma gondii infects nearly one-third of the world's population. Due to the significant side effects of current treatment options, identifying safe and effective therapies seems crucial. Nanoparticles (NPs) are new promising compounds in treating pathogenic organisms. Currently, no research has investi …

مقال بحثي وصول مفتوح

Field Efficacy of Topical Nano-Liposomal Amphotericin B (Sina Ampholeish®) Alone or in Combination with Glucantime® and Cryotherapy on Human Cutaneous Leishmaniasis

Zahra Alizadeh, Mohammad Reza Shirzadi, Gholamreza Hassanpour وآخرون · Iranian Journal of Parasitology · 2023 · 10.18502/ijpa.v18i4.14241

Background: Cutaneous leishmaniasis (CL) is a parasitic disease that presents a broad spectrum of clinical features. Treatment of CL is problematic. We aimed to compare the field therapeutic efficacy of topical nanoliposomes containing 0.4% amphotericin B (Nano Lip-AmB) alone and in combination with cryotherapy and/or …

مقال بحثي وصول مفتوح

Visceral Leishmaniasis in Iran: An Update on Epidemiological Features from 2013 to 2022

Mehdi Mohebali, Gholamhossein Edrissian, Behnaz Akhoundi وآخرون · Iranian Journal of Parasitology · 2023 · 10.18502/ijpa.v18i3.13751

Background: Visceral leishmaniasis (VL) is one of the most important neglected tropical diseases. The zoonotic form of VL is endemic in some areas of Iran. We aimed to determine the status of VL identified in humans and canines in different parts of Iran from 2013 to 2022. Method: A national representative cross-sectio …

مقال بحثي وصول مفتوح

Molecular Identification of Cutaneous Leishmaniasis Species in the Northcentral Iranian Province of Alborz: Is There a New Focus on Cutaneous Leishmaniasis in the Province?

Susan Sheikhi, Aliehsan Heidari, Mehdi Mohebali وآخرون · Iranian Journal of Parasitology · 2023 · 10.18502/ijpa.v18i2.13191

Background: Cutaneous leishmaniasis (CL) is an endemic infection in the Middle East, including Iran that is also spreading to new foci. We aimed to determine the leishmaniasis species causing CL in Alborz province. Methods: Overall, out of 55-suspected CL patients referred to health centers in Alborz Province, north ce …

مقال بحثي وصول مفتوح

Associations between Toxoplasma gondii Infection and Multiple Sclerosis: A Case-Control Seroprevalence Study

Masoumeh Shahra, Hossein Keshavarz, محمد علي صحراييان وآخرون · Iranian Journal of Parasitology · 2023 · 10.18502/ijpa.v18i2.13182

Background: Currently, there are conflicting reports on the associations between Toxoplasma gondii infection and multiple sclerosis (MS) in humans. In the present study, a case–control study was carried out to assess associations between seropositivity to T. gondii infection and MS. Methods: This case-control study was …

مقال مراجعة وصول مفتوح

Toxoplasma gondii Infection in Immunocompromised Patients in Iran (2013-2022): A Systematic Review and Meta-Analysis

Aref Teimouri, Fatemeh Goudarzi, Kimia Goudarzi وآخرون · Iranian Journal of Parasitology · 2022 · 10.18502/ijpa.v17i4.11271

Background: Toxoplasma gondii infection (toxoplasmosis) has the potential to cause a serious disease in immunocompromised patients and can be fatal in this population. We conducted a systematic review and meta-analysis to assess comprehensively the pooled seroprevalence of toxoplasmosis among immunocompromised patients …

مقال بحثي وصول مفتوح

Chronic Toxoplasma gondii Infection Potentiates Parkinson’s Disease Course in Mice Model

Nima Firouzeh, Naser Ziaali, Vahid Sheibani وآخرون · Iranian Journal of Parasitology · 2021 · 10.18502/ijpa.v16i4.7863

Background: Toxoplasma gondii is a neuroinvasive protozoa pathogen that could manipulate its intermediate host's behavior. However, the possible link between T. gondii infection and the development of neurodegenerative disorders such as Parkinson’s disease (PD) has been proposed, we tested the hypothesis that in chroni …

مقال بحثي وصول مفتوح

The Drug Resistance of Plasmodium falciparum and P. vivax in Iran: A Review Article

Aliehsan Heidari, Hossein Keshavarz · Iranian Journal of Parasitology · 2021 · 10.18502/ijpa.v16i2.6265

Background: One of the main obstacles to malaria control in the world has been the emergence of resistance in Plasmodium falciparum to chloroquine and other antimalarial drugs. This study aimed to review studies in Iran on resistance in P. falciparum and P. vivax to drugs, and to reveal the mechanisms and molecular mar …

مقال بحثي وصول مفتوح

The Emergence of Co-Infection of Visceral Leishmaniasis in an Iranian Child with Chronic Granulomatous Disease: A Case Report

Mohammad Reza Abdolsalehi, Mehdi Mohebali, Hossein Keshavarz وآخرون · Iranian Journal of Parasitology · 2021 · 10.18502/ijpa.v16i1.5536

Chronic granulomatous disease (CGD) described as an essential immunodeficiency problem of phagocytic cells resulting in a phagocyte dysfunction and inability to kill a spectrum of bacteria and fungi. Despite the fact that CGD patients are more susceptible to intracellular infections, visceral leishmaniasis has been rep …

مقال بحثي وصول مفتوح

Blood Donor Deferrals for Malaria in Iran: A Five-Year Retrospective Study

Ahmad Mardani, Hossein Keshavarz · Iranian Journal of Parasitology · 2019 · 10.18502/ijpa.v14i2.1146

BACKGROUND: Malaria is one of the most important transfusion-transmitted infections (TTIs) worldwide. To prevent the occurrence of transfusion-transmitted malaria (TTM), potential blood donors with a history of malaria or travel to, or residence in, malarious areas are permanently or temporarily deferred from donating …

المؤلفون المشاركون